Doximity, Inc. (DOCS) vs Erasca, Inc. (ERAS)
A side-by-side comparison of Doximity, Inc. and Erasca, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DOCS
Doximity, Inc.
$28.17HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
ERAS
Erasca, Inc.
$14.27HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — DOCS vs ERAS
growth of $100 · dividends reinvested · last 5yDOCS -46.0% (-11.6%/yr)ERAS -15.5% (-3.3%/yr)ERAS compounded faster over this window
DOCS ERAS
DOCS vs ERAS: by the numbers
- •DOCS is the larger company ($5.27B vs $4.96B market cap).
- •DOCS is profitable (25.48% net margin) while ERAS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | DOCS | ERAS |
|---|---|---|
| P/E ratio | 33.14 | N/A |
| Forward P/E | 20.91 | N/A |
| PEG ratio | 0.63 | N/A |
| P/S ratio | 8.04 | N/A |
| P/B ratio | 5.75 | 13.69 |
| EV / EBITDA | 23.65 | N/A |
| FCF yield | 5.68% | N/A |
Profitability
| Metric | DOCS | ERAS |
|---|---|---|
| Gross margin | 88.07% | 0.00% |
| Operating margin | 29.60% | 0.00% |
| Net margin | 25.48% | 0.00% |
| ROE | 18.24% | -79.37% |
| ROIC | 15.35% | -38.03% |
Growth (annualized)
| Metric | DOCS | ERAS |
|---|---|---|
| Revenue CAGR (5Y) | 21.94% | N/A |
| EPS CAGR (5Y) | 54.32% | N/A |
| FCF CAGR (5Y) | 23.75% | N/A |
| Total return CAGR (5Y) | -18.23% | -8.34% |
Frequently asked
- Is DOCS or ERAS more profitable?
- DOCS runs the higher net margin — DOCS at 25.48% versus ERAS at 0.00%.
- How have DOCS and ERAS total returns compared?
- Over the past 5 years, DOCS delivered -18.23% and ERAS delivered -8.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Doximity P/E ratioDoximity ROEErasca ROEDoximity operating marginErasca operating marginDoximity revenue growthErasca revenue growthDoximity free cash flowErasca free cash flow
Doximity & Erasca appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.